An optimal design of cumulative sum control chart based on median run length
暂无分享,去创建一个
[1] J. Smillie,et al. Unlinked surveillance of the prevalence of HIV infection in antenatal patients in the west Midlands, England , 1991, Journal of medical virology.
[2] M. S. Patel,et al. Optimum two stage group-screening with unequal group sizes and with errors in decisions , 1987 .
[3] S Zeger,et al. Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera , 1989, Journal of clinical microbiology.
[4] M. Bassett,et al. Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries. , 1988, Journal of clinical pathology.
[5] M. S. Patel. GROUP-SCREENING WITH MORE THAN TWO STAGES , 1962 .
[6] G. Watson. A Study of the Group Screening Method , 1961 .
[7] R. Coker,et al. Prevalence of hepatitis C in tropical communities: The importance of confirmatory assays , 1991, Journal of medical virology.
[8] J. Gaudino,et al. Sensitivity and specificity of pooled versus individual sera in a human immunodeficiency virus antibody prevalence study , 1989, Journal of clinical microbiology.
[9] R. Dorfman. The Detection of Defective Members of Large Populations , 1943 .
[10] M. Just,et al. HIV-1, hepatitis (A,B, and C), and measles in Romanian children , 1990, The Lancet.
[11] T. Quinn,et al. Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. , 1990, AIDS.
[12] W W Hauck,et al. Confidence intervals for seroprevalence determined from pooled sera. , 1991, Annals of epidemiology.
[13] Milton Sobel,et al. Finding a Single Defective in Binomial Group-Testing , 1971 .
[14] M. S. Patel,et al. Two stage woth unequal a-prior probabilities , 1984 .
[15] B. Kinosian,et al. Strategies for screening blood for human immunodeficiency virus antibody. Use of a decision support system. , 1990, JAMA.
[16] J. Sninsky,et al. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. , 1991, The New England journal of medicine.
[17] W. Reeves,et al. Statistical estimation of virus infection rates in mosquito vector populations. , 1962, American journal of hygiene.
[18] M. Houghton,et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. , 1990, British medical bulletin.
[19] H. Siitari,et al. New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay , 1990, Journal of clinical microbiology.